Disclosures for "Additional Efficacy Data Support Selection of Pilavapadin 10mg for Phase Three Development in DPNP: Results From PROGRESS"
-
Dr. Gopinathan has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Dr. Gopinathan has stock in Lexicon Pharmaceuticals.
-
Dr. Granowitz has received personal compensation for serving as an employee of Lexicon Pharmaceuticals . Dr. Granowitz has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Lexicon Pharmaceuticals . Dr. Granowitz has stock in Lexicon Pharmaceuticals .
-
Dr. Hardin has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Dr. Hardin has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Kappa Psi Pharmaceutical Fraternity. Dr. Hardin has stock in Lexicon Pharmaceuticals.
-
Mr. Banks has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Mr. Banks has stock in Lexicon Pharmaceuticals.
-
Author has nothing to disclose
-
Ms. Girard has nothing to disclose.